CompletedPhase 3NCT01132326

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)

Studying Dopamine beta-hydroxylase deficiency

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Chelsea Therapeutics
Principal Investigator: Horacio Kaufmann, MD
NYU Langone Health
Intervention: Droxidopa(drug)
Enrollment: 350 enrolled
Eligibility: 18 years · All sexes
Timeline: 2009 – 2013

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01132326 on ClinicalTrials.gov

← Back to all trials